Click to view our accessibility statement Skip to main content
By continuing to use this site, you agree to our use of cookies as described in our Cookie Policy.
This site contains information intended only for US healthcare professionals involved in the management of people with tardive dyskinesia.
This website is part of a disease-awareness, non-CME program sponsored by Neurocrine Biosciences and hosted by Current Psychiatry.
mind-td logo
The MIND-TD Faculty have been compensated by Neurocrine Biosciences, Inc.
  • About
  • Impact
  • Screening
  • Differential Diagnosis
  • Case Studies
  1. Home
  2. Case Studies
  3. Hypothetical Patients
  4. 31-Year-Old Woman With Schizophrenia and Generalized Anxiety Disorder
mind-td logo
The MIND-TD Faculty have been compensated by Neurocrine Biosciences, Inc.
  • About
  • Impact
  • Screening
  • Differential Diagnosis
  • Case Studies
  1. Home
  2. Case Studies
  3. Hypothetical Patients
  4. 31-Year-Old Woman With Schizophrenia and Generalized Anxiety Disorder

Case Studies

31-Year-Old Woman With Schizophrenia and Generalized Anxiety Disorder

    Share:
  • share via your computer's mail program
3-min watch


FACULTY CONTRIBUTOR

Portrait picture of Michelle Shamblin, RN,<br>APMHNP-BC, CARN-AP
Michelle Shamblin, RN,
APMHNP-BC, CARN-AP
Adjunct Professor
Department of Nursing
University of Texas at Arlington
Arlington, TX
Private Practice
Grapevine, TX

Recommended Next

The MIND-TD Questionnaire
Read More | 5-min read
61-Year-Old Man With Tardive Dyskinesia Showing Oro-Buccal-Lingual and Mandibular Stereotypy, Increased Blinking (Blepharoclonus), and Squinting/Grimacing (Blepharospasm), Worsened by Stress
Watch Now | 3-min watch
Screening for Tardive Dyskinesia: Best Practices in Person, Over Video, or via Telephone
Listen Now | 9-min listen

    Share:

  • share via your computer's mail program
Neurocrine Biosciences logo
  • Privacy Policy |
  • Cookie Policy |
  • Terms & Conditions |
  • Accessibility
©2022 Neurocrine Biosciences, Inc. All Rights Reserved.
MED-MSL-TD-US-0249 v2 CP-TD-US-0744 v3 07/2022
The MIND-TD website and educational content were sponsored and co-developed by Neurocrine Biosciences, Inc. The faculty have been compensated by Neurocrine Biosciences. This non-CME program is intended to provide general information about tardive dyskinesia and not medical advice for any particular patient. The content did not undergo peer review by Current Psychiatry.